| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 144,915109 | 25/08/2026 | 1,10% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 813,831247 | 25/08/2026 | 1,10% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 135,156920 | 25/08/2026 | 0,77% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 115,391871 | 25/08/2026 | 1,03% | · | ND |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | RVI BIOTECNOLOGÍA | 980,898106 | 26/08/2026 | 29,88% | 58,15% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | RVI BIOTECNOLOGÍA | 444,785329 | 26/08/2026 | 30,75% | 63,08% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | RVI BIOTECNOLOGÍA | 145,265233 | 26/08/2026 | 30,91% | 64,06% | *** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | 81,370000 | 26/08/2026 | -8,81% | 11,65% | * |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI CHINA | 66,510000 | 26/08/2026 | -8,14% | 15,23% | * |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACC | RVI CHINA | 86,540000 | 26/08/2026 | -6,36% | 13,45% | * |
